ShockWave Medical, Inc.
SWAV · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $12 | $7 | $7 | $10 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $0 |
| Enterprise Value | $12 | $7 | $8 | $10 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 7.8% | 9.1% | 3.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 87.1% | 87.5% | 86.8% | 86.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 25.6% | 30.3% | 27.2% | 20.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 25.3% | 21.8% | 18.8% | 16% |
| EPS Diluted | 1.44 | 1.16 | 0.92 | 0.76 |
| % Growth | 24.1% | 26.1% | 21.1% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |